Whatis
AELMHU?
We are a non-profit association made up of pharmaceutical companies, specialised in rare diseases, that are committed to discovering, researching, developing and commercialising innovative therapies that improve the lives of patients and their families.
AccessReport
AELMHU prepares, on a quarterly and annual basis,
reports on access to orphan drugs in Spain.
NEWS
NEWS
With the aim of highlighting the benefits of orphan therapies, not only for patients and their families, but also in economic terms for the health system, the document "Differential aspects of orphan therapies" has been presented in ... Read more
III National Conference on Advanced Therapies for Rare Diseases
AELMHU on World Rare Diseases Day
AELMHU and CGCOF promote knowledge of orphan drugs
AELMHU within the Strategic Plan of
Pharmaceutical Industry
INTERVIEWS
INTERVIEWS
Interview with the spokeswomen of the
working groups of AELMHU
Interview with Juan Carrión, president of the Spanish Federation of Rare Diseases (FEDER)
ASSOCIATED COMPANIES
RESEARCH AND COMMITMENT to rare diseases
MEMBERS
Do you want to be part of AELMHU?
